(RTTNews) – GSK Shopper Healthcare, a three way partnership between GlaxoSmithKline plc and Pfizer, Inc., is recalling kids’s Robitussin and Dimetapp over-the-counter cough syrups citing incorrect dosing cups that might end in overdose, the U.S. Meals and Drug Administration stated.
The recall includes the retail degree two a lot of Kids’s Robitussin Honey Cough and Chest Congestion DM and one lot of Kids’s Dimetapp Chilly and Cough.
The dosing cups for the Kids’s Robitussin Honey product are lacking the 5 mL and 10 mL graduations, whereas these for the Dimetapp product are lacking the 10 mL commencement. For each merchandise, the given dosing cups solely have the 20 mL commencement.
Kids’s Robitussin Honey Cough & Chest Congestion DM is labeled for kids four and older, in addition to adults. Kids’s Dimetapp Chilly & Cough is labeled for kids 6 and older, in addition to adults.
The affected tons have been distributed throughout america between February 5, 2020 and June 3, 2020. Robitussin’s lot numbers 02177 and 02178 expires in January 2022, whereas Dimetapp’s lot quantity CL8292 expires in September 2021.
The unintended overdose might end in impaired coordination; mind stimulation inflicting improve in vitality, elevation in blood strain, coronary heart fee, and respiration; and extreme dizziness or drowsiness, amongst others.
Nonetheless, GSK Shopper Healthcare has not but acquired any reviews of hostile occasions or client complaints associated to the recalled merchandise.
The views and opinions expressed herein are the views and opinions of the creator and don’t essentially replicate these of Nasdaq, Inc.
